BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9836756)

  • 41. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.
    Nicoll JA; McCarron MO
    Amyloid; 2001 Jul; 8 Suppl 1():51-5. PubMed ID: 11676291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
    Lee DW; Liu HC; Liu TY; Chi CW; Hong CJ
    Am J Med Genet; 2000 Apr; 96(2):167-9. PubMed ID: 10893490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
    Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
    Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy.
    Yamada M; Sodeyama N; Itoh Y; Otomo E; Matsushita M; Mizusawa H
    Stroke; 2002 Apr; 33(4):896-900. PubMed ID: 11935033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
    Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
    JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers.
    Lane RM; Darreh-Shori T; Junge C; Li D; Yang Q; Edwards AL; Graham DL; Moore K; Mummery CJ
    BMC Neurol; 2024 Apr; 24(1):116. PubMed ID: 38594621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease.
    Reddy JS; Allen M; Ho CCG; Oatman SR; İş Ö; Quicksall ZS; Wang X; Jin J; Patel TA; Carnwath TP; Nguyen TT; Malphrus KG; Lincoln SJ; Carrasquillo MM; Crook JE; Kanekiyo T; Murray ME; Bu G; Dickson DW; Ertekin-Taner N
    Acta Neuropathol Commun; 2021 May; 9(1):93. PubMed ID: 34020725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy.
    Christoforidis M; Schober R; Krohn K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):11-9. PubMed ID: 15634227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathologically Confirmed Cerebral Amyloid Angiopathy with No Radiological Sign in a Patient with Early Onset Alzheimer's Disease.
    Kim SJ; Seo Y; Kim HJ; Na DL; Seo SW; Kim Y; Suh YL
    Yonsei Med J; 2018 Aug; 59(6):801-805. PubMed ID: 29978619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.
    Greenberg SM; Rebeck GW; Vonsattel JP; Gomez-Isla T; Hyman BT
    Ann Neurol; 1995 Aug; 38(2):254-9. PubMed ID: 7654074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.
    Biffi A; Shulman JM; Jagiella JM; Cortellini L; Ayres AM; Schwab K; Brown DL; Silliman SL; Selim M; Worrall BB; Meschia JF; Slowik A; De Jager PL; Greenberg SM; Schneider JA; Bennett DA; Rosand J
    Neurology; 2012 Jan; 78(5):334-41. PubMed ID: 22262751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K).
    Grubber JM; Saunders AM; Crane-Gatherum AR; Scott WK; Martin ER; Haynes CS; Conneally PM; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Neurosci Lett; 1999 Jul; 269(2):115-9. PubMed ID: 10430518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
    Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
    Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee JH; Lee KU; Lee DY; Youn JC; Youn JY; Woo JI
    J Neural Transm (Vienna); 2001; 108(10):1159-66. PubMed ID: 11725818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis.
    Rannikmäe K; Samarasekera N; Martînez-Gonzâlez NA; Al-Shahi Salman R; Sudlow CL
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):901-8. PubMed ID: 23457231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.
    Simão-Silva DP; Bertolucci PH; de Labio RW; Payão SL; Furtado-Alle L; Souza RL
    Chem Biol Interact; 2013 Mar; 203(1):358-60. PubMed ID: 23022600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant.
    Olichney JM; Hansen LA; Galasko D; Saitoh T; Hofstetter CR; Katzman R; Thal LJ
    Neurology; 1996 Jul; 47(1):190-6. PubMed ID: 8710076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease.
    Olichney JM; Hansen LA; Lee JH; Hofstetter CR; Katzman R; Thal LJ
    Ann N Y Acad Sci; 2000 Apr; 903():138-43. PubMed ID: 10818499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.